Please ensure Javascript is enabled for purposes of website accessibility

Welcome to Regulatory Rapporteur. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
topra-logo

The Organisation for Professionals in Regulatory Affairs
Site name
Mast navigation
  • Become a member
  • Sign in
Search our site
Menu
Close menu
  • Regulatory Rapporteur - December 2024
  • Pharmaceuticals
    • Back to parent navigation item
    • Pharmaceuticals
    • Artificial intelligence
    • ATMP
    • Biologics
    • Chemistry, manufacturing and controls
    • Clinical trials
    • Non-clinical development
    • Oncology
    • Product information
    • Regulatory procedures
  • Veterinary
  • Medical devices
    • Back to parent navigation item
    • Medical devices
    • Combination products
    • In-vitro diagnostics
    • Software
    • Artificial intelligence
  • Industry news
    • Back to parent navigation item
    • Industry news
    • Industry news
      • Back to parent navigation item
      • Industry news
      • Read latest news
      • Video
  • Commentary
    • Back to parent navigation item
    • Commentary
    • Editorials
    • Letters to the Editor
    • Podcasts
  • Collections
    • Back to parent navigation item
    • Collections
    • Interviews
    • Symposium 2024
      • Back to parent navigation item
      • Symposium 2024
      • Annual lecture
    • Symposium 2023
      • Back to parent navigation item
      • Symposium 2023
      • Annual lecture
    • Symposium 2022
      • Back to parent navigation item
      • Symposium 2022
      • Annual lecture
    • Symposium 2021
      • Back to parent navigation item
      • Symposium 2021
      • Annual lecture
    • CPD supplements
      • Back to parent navigation item
      • CPD supplements
      • 2021/2022
      • 2020
      • 2019
  • JOIN TOPRA
  • topra-logo

    The Organisation for Professionals in Regulatory Affairs
  • Regulatory Rapporteur - December 2024
  • Pharmaceuticals
      • Artificial intelligence
      • ATMP
      • Biologics
      • Chemistry, manufacturing and controls
      • Clinical trials
      • Non-clinical development
      • Oncology
      • Product information
      • Regulatory procedures
    • CTR article image final
      Transitioning to the Clinical Trials Regulation: The Roche experience
    • RR-Dec-2024-Half-cover
      December 2024 – Contents
    • RR-Nov-2024-Half-Cover
      November 2024 – Contents: Human medicines sessions
  • Veterinary
    • RR-Nov-2024-Half-Cover
      November 2024 – Contents: Veterinary medicines sessions
    • SUSIMPERATIVE_compressed
      The sustainability imperative for the healthcare sector
    • AdobeStock_537705324
      New data protection for maximum residue limits
    • AdobeStock_294025271
      EMA platform to monitor use of antimicrobials
  • Medical devices
      • Combination products
      • In-vitro diagnostics
      • Software
      • Artificial intelligence
    • RR-Nov-2024-Half-Cover
      November 2024 – Contents: Medical devices/IVDs sessions
    • elabels image_compressed
      E-labelling: revolutionising the labelling landscape
    • AdobeStock_841428142_compressed
      New approach methodologies for the biological safety assessment of medical devices
  • Industry news
      • Industry news
        • Read latest news
        • Video
    • final alzimer article image
      Increased debate over lecanemab
    • EMA medicine shortages final image
      Use of new EMA platform for monitoring medicine shortages to become mandatory
    • GSK blood cancer article final image
      GSK Blenrep trial shows ‘significant overall survival benefit’of myeloma treatment
  • Commentary
      • Editorials
      • Letters to the Editor
      • Podcasts
    • AdobeStock_282144604

      North America:
      Navigating key regulatory updates
    • Michael Kipping
      Improving health outcomes through regulatory excellence
    • AdobeStock_971129498_SMALL
      Chemistry, manufacturing and controls: accelerating development and boosting innovation
  • Collections
      • Interviews
      • Symposium 2024
        • Annual lecture
      • Symposium 2023
        • Annual lecture
      • Symposium 2022
        • Annual lecture
      • Symposium 2021
        • Annual lecture
      • CPD supplements
        • 2021/2022
        • 2020
        • 2019
    • Banner_new
      Streamline medical device compliance with BSI Compliance NavigatorSponsored by The UK's National Standards Body
    • AdobeStock_59790119
      The Olaratumab experience
    • AdobeStock_207448226
      Qualification of stride velocity endpoint in Duchenne Muscular Dystrophy
  • JOIN TOPRA
  • More from navigation items
Pharmaceuticals

November 2024 – Contents

  • No comments

 

RR-Nov-2024-Half-Cover

Regulatory
Rapporteur

 

Write to the Editor at publications@topra.org

November 2024  |  Vol. 21  |  No. 10

 

EDITORIAL

Improving health outcomes through regulatory excellence

Cover option 1 MichaelKipping

READ HERE

By Kornelia Grein, Sobhey Nassar and Marie Uguen

 

HUMAN MEDICINES

Human medicines sessions

SabineHaubenreisser

READ THE SESSION SUMMARIES HERE

 

MEDICAL DEVICES/IVDS

Medical devices/IVDs sessions   

MD1 -MargarethJorvid

READ THE SESSION SUMMARIES HERE

 

VETERINARY MEDICINES

Veterinary medicines sessions

VM1 - RickClayton

READ THE SESSION SUMMARIES HERE

 

PARALLEL SESSION

PS1: Resolving specific development hurdles via scientific advice

PS1 - SandraLourenço

READ HERE

By Ophélie Poujade

 

PARALLEL SESSION

PS2: Patient experience data – The next steps towards medicines evaluation

PS2 - JuanGarciaBurgos

READ HERE

By Anna Koptina

 

SME, ACADEMIA AND START-UPS

SME: Regulatory updates for SME, academia and start-ups

SME -MarjonPasmooij

READ HERE

By Marie Uguen

 

ANNUAL LECTURE

The TOPRA annual lecture: Status of global health  

AnnualLecture - IlonaKickbusch

READ HERE

By Margareth Jorvid

 

Topics

  • 2024
  • Human medicines
  • IVD
  • Medical Devices
  • November 2024
  • Pharmaceuticals
  • Symposium 2024
  • Veterinary
  • No comments

More from Pharmaceuticals

  • AnnualLecture - IlonaKickbusch

    Journal

    TOPRA annual lecture: Status of global health

    2024-11-08T06:55:00Z By Margareth Jorvid

  • HM9 - ChristineGrew

    Journal

    HM9: Clinical trial applications - EU Clinical Trial Regulation and beyond

    2024-11-08T06:53:00Z By Christine Grew

  • HM8 - CarlosLangezaal

    Journal

    HM8: How the new EU regulation on health technology assessment (HTA) will change clinical drug development and regulatory affairs

    2024-11-08T06:53:00Z By David Uguen

  • HM6 - RebeccaLumsden

    Journal

    HM6: Artificial Intelligence – How will AI and machine learning tools transform regulatory practice?

    2024-11-08T06:52:00Z By Natasha Bankowski

  • HM7 - Denise Umuhire

    Journal

    HM7: Clinical evidence generation in Europe – Is it time for a more holistic view of global healthcare product development?

    2024-11-08T06:52:00Z By Michelle Blake

  • HM1 - SabineHaubenreisser

    Journal

    HM1: Ensuring regulatory excellence

    2024-11-08T06:51:00Z By Sandra Lourenço

  • HM3 - FrancescaButtigieg

    Journal

    HM3: Regulation and innovation – Keeping up with the times (Fireside chat)

    2024-11-08T06:51:00Z By Céline Combet

  • HM4 - KatjaPečjakReven

    Journal

    HM4: Electronic product information (ePI) – A digital passport for medicinal product information

    2024-11-08T06:51:00Z By Sarah Heraghty

Related articles

  • RR-Dec-2024-Half-cover

    Contents

    December 2024 – Contents

  • VM5 - IvoClaassen

    Journal

    VM5: Exploring the future of veterinary regulatory affairs – Harnessing science and innovation for animal health excellence

    2024-11-08T06:58:00Z By Jana Schalansky

  • VM4 - TomPaternoster-Howe

    Journal

    VM4: Advancing veterinary pharmacovigilance – Insights into signal management, first experiences with PhV inspections and introducing the EMA-ADR Data Quality Framework

    2024-11-08T06:58:00Z By Kornelia Grein

  • VM3 - RhonaMcHugh

    Journal

    VM3: Navigating the regulatory landscape of veterinary product information

    2024-11-08T06:57:00Z By Catarina Ferreira

  • VM1 - RickClayton

    Journal

    VM1: Advancing regulatory policies for One Health – A holistic approach to animal and public health

    2024-11-08T06:57:00Z By Kornelia Grein

  • VM2 - StéphanieGalleau

    Journal

    VM2: Progress in veterinary regulatory procedures – Opportunities and threats concerning the implementation of Regulation (EU) 2019/6

    2024-11-08T06:57:00Z By Rick Clayton

  • MD5 - NatashaBankowski

    Journal

    MD5/IVD5: Responsible and experienced PRRCs for MDR and IVDR

    2024-11-08T06:57:00Z By Rachel Drapela

  • MD4 - AshleighBatchen

    Journal

    MD4/IVD4: UK MDR – Current requirements and future perspectives for medical devices and in vitro diagnostics

    2024-11-08T06:56:00Z By Mehryar Behizad

No comments yet

You're not signed in.

Only registered users can comment on this article.

Sign in Register
  • What is Regulatory Affairs?
  • TOPRA Membership
  • Regulatory Rapporteur Editorial Board
  • Regulatory Rapporteur Editorial Area
  • Future Focus Topics
  • FAQs
  • Glossary
  • Privacy Policy
  • ISSN 2755-5070 (online)

    ISSN 1742-8955 (print - legacy)

Regulatory Rapporteur

The peer-reviewed journal, published 11 times per year and available free to TOPRA members.

Follow TOPRA
topra-logo

The Organisation for Professionals in Regulatory Affairs

TOPRA office
TOPRA Publishing, 6th Floor, 3 Harbour Exchange, South Quay, London E14 9GE, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org

TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70

  • Contact us
  • Copyright © 2015-2024 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved

Site powered by Webvision Cloud